ENEOSホールディングスは12月5日、NVIDIAが提供するAI駆動型化学・材料探索プラットフォーム「NVIDIA ALCHEMI」を活用し、次世代の液浸冷却液および酸素発生反応（OER）触媒の探索と最適化の加速に成功したと発表した。

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

The Faculty of Life Sciences & Medicine at King's has launched a new master's programme in Biotechnology and Computational ...

to join the Research Council of Finland Center of Excellence in Life Inspired Hybrid Materials (LIBER).

AI therapeutics company built on causal biology, today announced the appointment of two scientific advisors: Stephen Hitchcock, Ph.D., a preeminent drug development leader and former Chief Scientific ...